Clinical trials represent the crucial interface between innovative cancer research and successful therapy. They provide patients with direct access to the cutting-edge therapeutic developments and offer them the opportunity to benefit immediately from current research results. Around 500 oncological clinical studies are currently being conducted at the National Center for Tumor Diseases (NCT) in Heidelberg. These include both investigator-initiated trials (IITs) and industry-sponsored trials (ISTs). Information for patients on clinical studies can be found in the section “For Patients”.
Clinical Trials at NCT Heidelberg
All non-pediatric trials conducted at NCT Heidelberg are listed here, categorized by entity or research area. They are further classified by first-line therapy, subsequent lines of therapy, surgical, and radiation therapy, as well as other trials. Clicking on an individual study reveals additional details, such as the full title, the trial phase, contact details of the contact person, the principal investigator, and link(s) to registry entries.
Information on pediatric oncology can be found here.
Search for Clinical Trials at NCT Heidelberg and Beyond
Directories for oncological clinical trials with search function
All open clinical trials conducted at NCT Heidelberg can be found on the trial platforms QuickQueck and CCC-trials.de. These platforms offer various search functions to support users in finding a specific trial. They also list studies conducted at other locations, which can be filtered accordingly. This section further contains a link to the clinical trials offered by Mannheim Cancer Center.
On the website CCC-trials.de, funded by the German Cancer Aid (DKH) through the ONCOnnect project, open clinical trials from all leading German cancer centers (Comprehensive Cancer Centers) can be found. If required, trials that have already been completed can also be displayed. The platform allows filtering by location, line of therapy, biomarkers, patient’s age, and study status, as well as to use keyword or free-text searches.
On the QuickQueck online platform, all active clinical trials at NCT Heidelberg as well as additional oncology trials conducted at other sites that are recruiting in Germany can be found. The platform enables physicians and patients to perform quick and targeted searches. Multiple keywords can simply be entered separated by a space—for example, UVEA Heidelberg.
A suitable trial in the area can be found at our partner site, Mannheim Cancer Center at the University Medical Center Mannheim (UMM).
Clinical Trials Hotline for Physicians
If you are a medical colleague and have any questions about our oncological systemic therapy studies, you can now contact us directly by calling our study hotline at 06221 -56 32884. The hotline is available Monday through Thursday from 9:00 a.m. to 4:00 p.m. and Friday from 9:00 a.m. to 2:00 p.m. If you are unable to reach us, we may be on another call or you may be calling outside of our office hours. In this case, please leave your name, your request, and your phone number after the tone. We will call you back as soon as possible. If you are a patient or relative, please direct your inquiry to the contacts listed.
Clinical Trials Newsletter
The NCT Heidelberg Clinical Trials Newsletter provides quarterly updates featuring selected highlight trials. The newsletter can be subscribed here. The newsletter complies with GDPR regulations and can be unsubscribed at any time. This newsletter is available in German only.
Information for sponsors, CROs, and trial networks
Study Requests and Feasibility Assessment
Sponsors, CROs, research networks, etc., please send your study request directly to the appropriate study team, according to the e-mail contact list below. You will receive prompt feedback, once the feasibility of your study request has been assessed. This flowchart shows our standard workflow for study/feasibility requests.
| Tumor/Area | Contact Person for Study/Feasibility Requests
|
| CUP (Carcinoma of Unknown Primary) | PD Dr. Tilmann Bochtler tilmann.bochtler(at)med.uni-heidelberg.de Prof. Dr. Alwin Krämer Alwin.Kraemer(at)med.uni-heidelberg.de |
Cross-Entity/Basket
| a) Prof. Dr. Guy Ungerechts b) Prof. Dr. Richard Schlenk |
Gastrointestinal Tumors
| a) Prof. Dr. Georg Martin Haag b) Dr. Sebastian Dieter c) Prof. Dr. Dr. Christoph Springfeld |
| Gynecological Tumors/Breast Cancer | Prof. Dr. Andreas Schneeweiss andreas.schneeweiss(at)med.uni-heidelberg.de |
| Hematological Neoplasms | Studienportal Innere Medizin V studienportal.med5(at)med.uni-heidelberg.de |
| Skin Tumors | Prof. Dr. Jessica Hassel jessica.hassel(at)med.uni-heidelberg.de |
| Head and Neck Tumors | Dr. Sebastian Dieter sebastian.dieter(at)med.uni-heidelberg.de |
| Neuroendocrine Tumors | PD Dr. Leonidas Apostolidis leonidas.apostolidis(at)med.uni-heidelberg.de |
| Brain/CNS Tumors | Dr. Antje Wick antje.wick(at)med.uni-heidelberg.de |
| Phase 1 Studies | Prof. Dr. Guy Ungerechts guy.ungerechts(at)nct-heidelberg.de |
| Prevention | Prof. Dr. Hermann Brenner h.brenner(at)dkfz.de |
| Radiooncology | Prof. Dr. Dr. Jürgen Debus studien.radonk(at)med.uni-heidelberg.de |
| Sarcoma | Prof. Dr. Gerlinde Egerer Gerlinde.Egerer(at)med.uni-heidelberg.de PD Dr. Leonidas Apostolidis leonidas.apostolidis(at)med.uni-heidelberg.de |
| Supportive Therapy | NCT Studienportal studienportal.nct(at)med.uni-heidelberg.de |
| Thoracic Tumors | Prof. Dr. Michael Thomas Studienkoordination-Onkologie.THOR(at)med.uni-heidelberg.de |
| Urogenital Tumors | PD Dr. Stefanie Zschäbitz stefanie.zschaebitz(at)med.uni-heidelberg.de |